A prefilled syringe is a comparatively new product in the pharmaceutical market which has accelerated its pace gradually and has become an important option in the packaging and delivery of injectable drug products. This prefilled syringe is an innovation in parenteral packaging, which contains a single dose in a primary sterile container and a delivery system which is filled aseptically with an injectable drug. Primarily, the most commonly used therapeutic categories in the prefilled syringe format are anticoagulants, antivirals, anaphylaxis, hematopoietic, monoclonal antibodies and vaccines. Prefilled syringes are helping pharmaceutical companies to minimize drug wastage and increase product lifespan, while helping the patients to self-administer injectable drugs at their homes.

The global prefilled syringes market is very dynamic, filled with intense competition. The future prospect of this market looks promising as the market is driven by factors such as accurate drug dosing, negligible overfill requirements, no preservatives required in the formulation, increased assurance of sterility, ease of use and handling, time saving in emergency situations, and reduced material cost, among others. These are some of the major advantages provided by prefilled syringes, as a result of which, prefilled syringes sector is one of the fastest growing segments of the injectable drug delivery devices market.

The prevalence of chronic diseases have increased worldwide and thus, there is a growing demand for and higher production of large molecule biologics and bio-similars. Furthermore, the integration of autonomous inbuilt safety mechanisms with the constant innovation in prefilled syringes and a high penetration rate of self-injection devices in the market are collectively driving the global prefilled syringes market towards an exponential growth. The global market is expected to grow at a CAGR of 10.75% from 2017 to 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the period of 2017 to 2021.

The companies in the market are being pushed towards innovation and development of new products as safety plastic prefilled syringes have witnessed a huge surge in their demand owing to their convenience and cost effectiveness. Emerging markets in the industry such as Japan, China, Australia, and India are exhibiting ample opportunities to the market players for market penetration. Europe is leading the market at present owing to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory practices regarding combination products and high cost of manufacturing are hampering the growth of global prefilled syringes market. Although, viable opportunities for the market players are being projected due to increasing biologics and biosimilar in the market, and in the form of market penetration, establishment and outreach of major key players in the emerging markets.

BIS Healthcare has conducted an extensive market research on ‘Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021’. The market intelligence report aims to provide an in-depth analysis of the key development strategies, marketing strategies and market trend dynamics which includes drivers, restraints, and opportunities prevailing in the industry.

For further queries, please write to us at sales@bisresearch.com or call us at: +1 650 228 0182.